Maintenance of successful ritonavir-boosted indinavir and efavirenz therapy in an HIV-infected patient with tuberculosis

被引：2
|
作者：
Boyd, MA [1 ]
Burger, DM
Phanuphak, P
Cooper, DA
机构：
[1] Flinders Univ S Australia, Dept Microbiol & Infect Dis, Bedford Pk, SA 5042, Australia
[2] Radboud Univ, Med Ctr, Dept Clin Pharm, Nijmegen, Netherlands
[3] Thai Red Cross AIDS Res Ctr, Bangkok, Thailand
[4] Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW, Australia
来源：
AIDS | 2006年 / 20卷 / 07期
关键词：
D O I：
10.1097/01.aids.0000222090.52035.b2
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1083 / 1085
页数：3
相关论文
共 50 条
  • [21] Pharmacokinetic Study of the Variability of Indinavir Drug Levels when Boosted with Ritonavir in HIV-Infected Children
    Curras, Veronica
    Hoecht, Christian
    Mangano, Andrea
    Niselman, Viviana
    Marino Hernandez, Eduardo
    Ceceres Guido, Paulo
    Mecikovsky, Debora
    Bellusci, Carolina
    Bologna, Rosa
    Sen, Luisa
    Rubio, Modesto C.
    Bramuglia, Guillermo F.
    [J]. PHARMACOLOGY, 2009, 83 (01) : 59 - 66
  • [22] Safety and exposure of once-daily ritonavir-boosted atazanavir in HIV-infected pregnant women
    Conradie, F.
    Zorrilla, C.
    Josipovic, D.
    Botes, M.
    Osiyemi, O.
    Vandeloise, E.
    Eley, T.
    Child, M.
    Bertz, R.
    Hu, W.
    Wirtz, V.
    McGrath, D.
    [J]. HIV MEDICINE, 2011, 12 (09) : 570 - 579
  • [23] Darunavir minimum plasma concentration and ritonavir-boosted darunavir monotherapy outcome in HIV-infected patients
    Gutierrez-Valencia, Alicia
    Torres-Cornejo, Almudena
    BenMarzouk-Hidalgo, Omar J.
    Ruiz-Valderas, Rosa
    Lluch, Amparo
    Viciana, Pompeyo
    Lopez-Cortes, Luis F.
    [J]. ANTIVIRAL THERAPY, 2014, 19 (05) : 443 - 447
  • [24] Impact of nevirapine or efavirenz coadministration and fosamprenavir daily regimen on ritonavir-boosted amprenavir pharmacokinetics in HIV infected patients
    Dailly, E.
    Raffi, F.
    Biron, C.
    Allavena, C.
    Jolliet, P.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2007, 21 : 39 - 39
  • [25] Pharmacokinetics of indinavir/ritonavir (800/100 mg twice a day) combined with efavirenz in HIV-infected patients
    Aarnoutse, RE
    Brinkman, K
    Benetucci, J
    Begovac, J
    Stek, M
    Burger, DM
    [J]. AIDS, 2004, 18 (03) : 565 - 567
  • [26] Viral decay dynamics in HIV-infected patients receiving ritonavir-boosted saquinavir and efavirenz with or without enfuvirtide: A randomized, controlled trial (HIV-NAT 012)
    Boyd, Mark A.
    Dixit, Narendra M.
    Siangphoe, Umaporn
    Buss, Neil E.
    Salgo, Miklos P.
    Lange, Joep M. A.
    Phanuphak, Praphan
    Cooper, David A.
    Perelson, Alan S.
    Ruxrungtham, Kiat
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2006, 194 (09): : 1319 - 1322
  • [27] Low-doses of indinavir boosted with ritonavir in HIV-infected Thai patients: pharmacokinetics, efficacy and tolerability
    Cressey, TR
    Leenasirimakul, P
    Jourdain, G
    Tod, M
    Sukrakanchana, P
    Kunkeaw, S
    Puttimit, C
    Lallemant, M
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 55 (06) : 1041 - 1044
  • [28] Changes in cardiovascular biomarkers in HIV-infected patients switching from ritonavir-boosted protease inhibitors to raltegravir
    Martinez, Esteban
    D'Albuquerque, Polyana M.
    Llibre, Josep M.
    Gutierrez, Felix
    Podzamczer, Daniel
    Antela, Antonio
    Berenguer, Juan
    Domingo, Pere
    Moreno, Xabier
    Perez, Ignacio
    Pich, Judit
    Gatell, Jose M.
    [J]. AIDS, 2012, 26 (18) : 2315 - 2326
  • [29] Current Efavirenz (EFV) or Ritonavir-Boosted Lopinavir (LPV/r) Use Correlates with Elevate Markers of Atherosclerosis in HIV-Infected Subjects in Addis Ababa, Ethiopia
    Gleason, Rudolph L., Jr.
    Caulk, Alexander W.
    Seifu, Daniel
    Parker, Ivana
    Vidakovic, Brani
    Getenet, Helena
    Assefa, Getachew
    Amogne, Wondwossen
    [J]. PLOS ONE, 2015, 10 (04):
  • [30] Switching from a ritonavir-boosted PI to dolutegravir as an alternative strategy in virologically suppressed HIV-infected individuals
    Negredo, Eugenia
    Estrada, Vicente
    Domingo, Pere
    del Mar Gutierrez, Maria
    Mateo, Gracia M.
    Puig, Jordi
    Bonjoch, Anna
    Ornelas, Arelly
    Echeverria, Patricia
    Estany, Carla
    Toro, Jessica
    Clotet, Bonaventura
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2017, 72 (03) : 844 - 849
12345